Important changes regarding butalbital containing products, Kentucky’s “exempt” controlled substances and anabolic steroids Effective September 17, 2014, changes to 902 KAR 55:045 and 902 KAR 55:090 were finalized

First Page		Document Content
Date: 2015-01-03 17:53:56 Barbiturates Butalbital Pharmacology Medical prescription DEA number Fioricet Drug Enforcement Administration Anabolic steroid Pharmacy Medicine Pharmaceutical sciences Alkenes		Important changes regarding butalbital containing products, Kentucky’s “exempt” controlled substances and anabolic steroids Effective September 17, 2014, changes to 902 KAR 55:045 and 902 KAR 55:090 were finalized Add to Reading List Source URL: www.chfs.ky.gov Download Document from Source Website File Size: 161,61 KB Share Document on Facebook

	Transtympanic steroids for treatment of sudden hearing loss GERARD J. GIANOLI, MD, FACS, and JOHN C. LI, MD, FACS, Baton Rouge, Louisiana, and Jupiter, Florida OBJECTIVES: To determine whether transtympanic steroid admin DocID: 1reNP - View Document
	World Surf LeagueAnti-Doping Policy Date: 5 January 2016 DocID: 1rdnF - View Document
	International Boxing Association Anti-Doping Rules Valid from January 1, 2015 Anti-Doping Rules are based on Wada’s Models of Best Practice for International Federations DocID: 1qlXo - View Document
	IPRC Indiana Prevention Resource Center IPRC DocID: 1qkbr - View Document
	Microsoft Word - IOC ADR - Final - RioGames of the XXXI Olympiad - IOC Anti-Doping Rules.docx DocID: 1qdR3 - View Document